Paper2245602
Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndrome.
Fisher CJ and 9 others. Crit Care Med, 1990. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndrome. Papers, record 2245602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2245602
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndrome.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Bacterial Proteins | Major topic |
| Endotoxins | Major topic |
| Gram-Negative Bacteria | Major topic |
| Lipid A | Major topic |
| Sepsis | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Dose-Response Relationship, Immunologic | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Models, Chemical | |
| Pilot Projects |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33066119 | Structure, Function, and Therapeutic Use of IgM Antibodies. | Antibodies (Basel) | 2020 | https://conductscience.org/library/papers/33066119 | PubMed |
| 24351718 | Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect. | Toxins (Basel) | 2013 | https://conductscience.org/library/papers/24351718 | PubMed |
| 22531443 | The birth pangs of monoclonal antibody therapeutics: the failure and legacy of Centoxin. | MAbs | 2012 | https://conductscience.org/library/papers/22531443 | PubMed |
| 18611565 | Biological response modifiers and infectious diseases: actual and potential therapeutic agents. | Int J Antimicrob Agents | 1994 | https://conductscience.org/library/papers/18611565 | PubMed |
| 11645897 | Delaying approval of a critical drug: safety, efficacy, economics, compassion. | J Med Humanit | 1994 | https://conductscience.org/library/papers/11645897 | PubMed |
| 7790040 | The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes. | Immunology | 1995 | https://conductscience.org/library/papers/7790040 | PubMed |
| 7590445 | A possible role for antibodies to tumour necrosis factor alpha and to endotoxin in the treatment of Reye's syndrome. | Gut | 1995 | https://conductscience.org/library/papers/7590445 | PubMed |
| 1571053 | Monoclonal antibodies in sepsis and septic shock. | BMJ | 1992 | https://conductscience.org/library/papers/1571053 | PubMed |
| 1444318 | Phase I study of antilipopolysaccharide human monoclonal antibody MAB-T88. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1444318 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2245602
GET https://conductscience.org/api/papers/v1/2245602/authors